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INTRODUCTION
Hepatitis C virus (HCV) infection represents 
a major public health problem in Brazil and 
in the world. Most of the cases are asymp-
tomatic HCV carriers, but chronic infection 
occurs in approximately 85% of the infected 
individuals that can progress into liver cir-
rhosis and hepatocarcinoma. The HCV was 
identified in 1989 by researchers from Chiron 
Corporation and it is responsible for about 
90% of the so-called non-A non-B hepatitis.1 
Presently, cirrhosis caused by chronic hepati-
tis C is the leading indication for liver trans-
plantation in United States of America2,3 and 
in Brazil.4
After tests to detect anti-HCV became 
available, a number of studies have been con-
ducted to estimate the prevalence of HCV 
infection in the general population.5-9 The 
World Health Organization (WHO) data 
suggests a worldwide prevalence of 2.2%-
3.0%, with the highest prevalence found in 
the African and the Eastern Mediterranean 
regions.10 Brazilian studies on this sub-
ject have been predominantly targeted risk 
groups11-14 and blood donors.15,16 Only few 
investigators have addressed the prevalence 
of hepatitis C in the general population or 
in minority groups.17 Focaccia et al., for ex-
ample, found 1.42% of anti-HCV positive 
results in the population of São Paulo.18 In 
Brazilian blood donors, the anti-HCV preva-
lence was found to be 1.6%.13 In the South 
Region the prevalence in general population 
and blood donors was estimated in 0.15%14,19 
and 0.46%,20 respectively.
Considering data from public health 
department, the Paraná State from 2003 to 
2006 has an accumulated detection of 21.11 
cases of hepatitis C per 100,000 inhabitants. 
But in Tamboara, this rate was estimated on 
581.95.21 Based on this fact, we conducted a 
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study to investigate the prevalence of anti-HCV in Tam-
boara residents and to elucidate the risk factors associat-
ed with HCV transmission in this population. The results 
should help sanitary authorities to set up policy decisions 
for Tamboara. For this community-based seroepidemiologi-
cal survey, HCV Rapid Test was used and validated by AR-
CHITECT quimioluminescent immunoassay.
MATERIALS AND METHODS
Study population
This study was performed in Tamboara, a small town 
with 4,564 inhabitants of the Paraná State, south Brazil. 
The town was divided in different areas which were vis-
ited by groups of two investigators. Each house of urban 
area has been systematically visited by a trained nursing 
student. One resident for each house, independently of 
age, was selected by at random and invited to partici-
pate in the study. Blood sample and a questionnaire on 
the risk factors for hepatitis C were obtained from each 
subject after the informed consent was signed. In the 
case of minors, the informed consent was signed by their 
parents. The questionnaire consist of questions regard-
ing demographic variables, familial history of hepatitis, 
various potential parenteral exposure to blood or blood 
products before and after 1993, history of parenteral in-
jections and intravenous drips, sexual behavior, as well 
as dental treatment, previous surgery, tattooing, etc. The 
study protocol was approved conformed to the ethical 
guidelines of the 1975 Declaration of Helsinki, as re-
flected in a priori approval by the institution’s Human 
Research Committee.
Laboratory testing
The HCV Rapid Test Bioeasy (Bioeasy Diagnostica Ltda, 
Minas Gerais, Brazil), an immuno-chromatographic as-
say for HCV antibodies qualitative detection was used 
according to the manufacturer’s instructions. Briefly, to-
tal blood from each subject was obtained by lancing de-
vice against the chosen puncture finger and 10µL was as-
pirated with a micropipette. The blood was deposited in 
a small slide and 3 drops of the reagent were added. After 
ten minutes, one column if negative or two columns if 
positive could be viewed. When the anti-HCV was posi-
tive by Rapid Test Bioeasy, the result was confirmed by 
ARCHITECT quimioluminescent immunoassay (Abbott 
Park, IL, USA), considered the gold standard for anti-
HCV detection. Ten percent of negative patients were in-
vited to confirm their test as well. Those subjects, whose 
results were positive in both tests, were further tested by 
PCR (Amplicor® Hepatitis C Virus – HCV – Test, ver-
sion 2.0, Roche, Branchburg, NJ, USA) for HCV RNA de-
tection and genotyping by kit VERSANTTM VERSANT 
HCV Genotype Assay (LiPA) (Bayer, Tarrytown, NY, 
USA), according to the manufacturer’s instructions. In 
a second step, the families’ members from HCV positive 
patients were contacted and invited to have their anti-
HCV status checked by Rapid Test Bioeasy. The positive 
results were than confirmed by PCR (Amplicor® Hepati-
tis C Virus – HCV – Test, version 2.0, Roche, Branchburg, 
NJ, USA) for HCV RNA detection.
Statistical analysis
Risk factors were compared between patients with posi-
tive or negative HCV testing using χ2 test or Fischer’s test 
as appropriated. For calculation of anti-HCV prevalence 
related to age, Student’s t-test was applied. Multivariate 
analysis was conducted using logistic regression, consid-
ering Wald test for variable significance. Rapid test was 
validated by sensibility and specificity determination. A 
p value < 0.05 was considered statistically significant.
RESULTS
Seroprevalence by age and gender
During a period of 4 days, 816 (17.87%) subjects of 
4,564 estimated residents in Tamboara were interviewed 
and tested for anti-HCV. The overall anti-HCV preva-
lence using Rapid Test Bioeasy was 4.28% (35 subjects), 
similar in males (3.85%) and females (4.53%). The anti-
HCV prevalence according to age is showed in Figure 1. 
The median age for positive and negative anti-HCV test 
was 60.49 (± 14.14) and 41.68 (± 20.25) years old respec-
tively, with a p value < 0.001.
Figure 1: Distribution of anti-HCV prevalence by age groups 
in the population of Tamboara, Brazil.
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Socioeconomic factors
The social-demographic variables are demonstrated in 
Table 1. Ethnic group and marital status were not asso-
ciated with presence of HCV infection. The prevalence 
of anti-HCV in subjects with no education or less than 
eight years of education was significantly higher than in 
the others (p = 0.012). Sadly, 15.14% of the population 
in Tamboara had less than one year of education.
Risk factors for hepatitis C
By univariate analysis, the significant risk factors 
for HCV infection were as follow: familial history 
of hepatitis (p = 0.04), injection with glass syringe 
(p < 0.001), vaccination with jet (needle-free) injec-
tion devices (p = 0.034), blood transfusion before 1993 
(p < 0.001) and not safe sexual practice (p = 0.03). 
By multivariate analysis, only familial history of hepa-
titis (p = 0.001; OR = 6.41; 95% CI = 2.08-19.78) and 
age (p = 0.007; OR 1.06; 95% CI = 1.02-1.10) showed 
statistically significant values (Table 2). Based on that, 
we constructed a ROC curve in order to identify an age 
associated to positive HCV status. After that, only par-
ticipants with more than 45 years (n = 362) of age were 
analyzed. By multivariate analysis of this group, familial 
history of hepatitis continued to be the only significant 
risk factor of HCV infection (p = 0.001; OR 5.08; 95% 
CI = 1.99-12.99) (Table 3).
Rapid Test Bioeasy performance
The sensibility and specificity of the Rapid Test 
Bioeasy was estimated considering quimiolumines-
cent immunoassay as gold standard for anti-HCV. 
Thirty three anti-HCV positive individuals and 41 
anti-HCV negative by immuno-chromatographic test 
were submitted to quimioluminescent immunoassay 
(Table 4). The sensitivity and specificity was 100.0% 
and 92.7% respectively, with an accuracy of 95.8% 
(95% CI = 91-100).
Table 1. Sociodemographic characteristics and anti-HCV positivity in the population of Tamboara, Brazil
    Anti-HCV 
 Category n (%)  Rapid Test Bioeasy
   Negative (%) Positive (%) p value
Gender
 Female 530 (64.95) 506 (95.47) 24 (4.53) 0.646
 Male 286 (35.05) 275 (96.15) 11 (3.85) 
Ethinic group
 Euroupeans 469 447 (95.31) 22 (4.69) 0.802
 Africans 111 107 (96.4) 4 (3.6)
 Asians 20 25 (89.29) 3 (10.71)
 Mixed race 200 194 (97) 6 (3)
 Native indians 8 8 (100) 0 (0)
Education
 0-7 years 437 409 (93.59) 28 (6.41) 0.012
 ≥ 8 years  316 309 (97.78)  7 (2.22)
Marital status
 (≥ 14 years)
 Never married, 286 275 (96.15) 11 (3.85) 
 divorced or     
0.526
 widower
 Married 469 445 (94.88) 24 (5.12)
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Genotype distribution
The prevalence of HCV genotypes is shown in Figure 2. 
Sixty-eight percent of positive anti-HCV residents were 
genotype 3 and only 11% were genotype 1.
Table 2. Risk factors associated with HCV among 
participants
Variable p value Odds ratio 
  (95% CI)
Years of education 0.208 2.49 (0.60-10.34)
Familial history 
0.001  6.41 (2.08-19.78)
of hepatitis
Surgery 0.829 0.88 (0.27-2.90)
Injection with 
0.612 1.54 (0.29-8.14)
glass syringe
Jet injection device 0.319  3.12 (0.33-29.51)
Sutures 0.758 0.85 (0.29-2.47)
Blood transfusion 
0.306 2.22 (0.48-10.29)
before 1993
Blood transfusion  
0.161 3.77 (0.59-24.31)
after 1993
Not safe sexual 0.490 2.14 (0.24-18.75)
practice
Age 0.007 1.06 (1.02-1.10)
Table 3. Risk factors associated with HCV in partici-
pants older than 45 years of age
Variable p value Odds ratio 
  (95% CI)
Familial history 
0.001 5.08 (1.99-12.99)
of hepatitis
Injection with 0.310 2.92 (0.37-23.26)
glass syringe
Blood transfusion 0.178 2.25 (0.69-7.35)
before 1993
Blood transfusion 0.082 3.82 (0.84-17.40)
after 1993
Table 4. Performance of the Rapid Test Bioeasy in 
the detection of anti-HCV
 Quimioluminescent 
Rapid Test Bioeasy immunoassay Total
 positive negative
positive 30 3 33
negative 0 38 38
total 30 41 71
Figure 2: Prevalence of hepatitis C virus genotypes in the 
population of Tamboara, Brazil.
HCV status from family members of positive 
residents
Seventy eight family members from 28 anti-HCV posi-
tive subjects were investigated for anti-HCV with 5 
(6.41%) of them showing positive results by Rapid Test 
Bioeasy and by PCR. The five anti-HCV positive were 
from 3 different families.
DISCUSSION
There are only few population-based studies on age-specifi c 
prevalence of HCV infection which demonstrate distinct epi-
demiologic profi les of HCV transmission worldwide. These 
profi les reﬂ ect not only regional variations but also variations 
in the period during which there was an increased risk for 
acquiring HCV infection. In Tamboara, the age-specifi c anti-
HCV prevalence is low in children and younger adults but in-
creases sharply among older persons, who account for most 
of the infected individuals. The data suggests that the burden 
of disease might have already peaked. This type of pattern was 
also seen in Spain,22 Italy6 and Japan23 and it is consistent with 
the fact that the risk for HCV infection was highest 30-50 years 
ago. Illegal use of injection drugs have been the dominant 
mode of HCV transmission in USA during the past 30 years7 
but it appears to have played a minor role in the population 
of Tamboara. In countries where the period of increased risk 
for HCV infection occurred in a distant past such as observed 
in this study, healthcare-related procedures performed both 
by professionals and nonprofessionals appear to have been a 
major mode of HCV transmission. The authorities respon-
sible for health care in Tamboara had a hypothesis that the 
high prevalence of anti-HCV was related with jet injection 
devices. Up to 1990, vaccination with this technique was used 
especially for prevention of yellow fever in Brazil. An epide-
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miological survey by Souto et al. in a Center-West Brazilian 
city suggests that the jet injection device has facilitated hepa-
titis B contamination in the population.24 In this study, some 
healthcare procedures related to anti-HCV transmission were 
identifi ed by univariate analysis. Injections with glass syringe, 
vaccination with jet injection devices and blood transfusion 
before 1993 were signifi cant risk factors. However, by multi-
variate analysis, these factors were not signifi cant.
In a recent survey, prevalence for anti-HCV ranging from 
0.69%-1.89% was observed in the capital cities of Northeast, 
Center-West and in Federal District of Brazil.25 In Tamboara, 
this prevalence was 4.3% is considered high for a place with 
not known risk factors. The strong relationship of risk of 
infection and the presence of family history of hepatitis sug-
gests that the transmission of HCV have occurred among 
family members, but does not defi ne the exact routes. As 
hypothesized by Rao et al., many infections in the past were 
probably acquired from external sources in which more than 
one family member was contaminated at the same time.26 
Nevertheless, the lower prevalence in younger age groups 
in Tamboara suggests that the unknown exposure may no 
longer play a role in HCV transmission.
According to Campiotto et al., the HCV genotype 1 is 
more prevalent in all regions of Brazil with a median frequen-
cy of 64.9% and in the South, genotype 3 was more common 
(43.2%) than in the other regions.27 Similar results were found 
by Focaccia et al.28 In hemodialysis patients from Central Bra-
zil, the genotype 3 was present in 7.6%.29 In Tamboara, the 
great majority of HCV individuals carry genotype 3.
The study found a 6.41% prevalence of anti-HCV in mem-
bers of the positive families. This data confi rms the important 
role of intrafamilial transmission in our population.
The accumulated incidence and anti-HCV prevalence in 
Tamboara has called the attention of local health care work-
ers. Thus, better knowledge regarding this HCV epidemic 
area was important for the government to take effective de-
cisions strategies. Based on this data, we now know that in-
fection occurred in a distant past and there is no longer risk 
behavior related to HCV. Efforts from government and local 
health workers will become necessary for treating already 
infected subjects. This effort will be extremely effi cient in 
avoiding cirrhosis and hepatocellular carcinoma and it will 
have a social economic result better than the HCV preven-
tion in Tamboara. The great majority of individuals infected 
by genotype 3 will become this strategy result even better 
and less expensive since genotype 3 virus has good response 
to interferon and ribavirin treatment.
By our knowledge, this epidemiological survey was the 
fi rst in Brazil to check the quality of the Rapid Test Bioeasy 
for anti-HCV as a screening test. The sensibility of a rapid 
immuno-chromatographic assay for the detection of anti-
HCV antibodies have been evaluated previously on 421 
HCV RNA positive samples from chronic carriers and com-
pared with enzyme-linked immunoassays (ELISA) meth-
od.30 The sensitivity of rapid test was 95.5% and false nega-
tive results were associated with human immunodefi ciency 
virus (HIV). Among HIV-negative people, the sensibility 
was 99.2% whereas among HIV positive one, this result was 
77.5%. In our study, a specifi city of 92.7% and accuracy of 
95.8% was observed for rapid test. Since Tamboara presents 
low HIV prevalence rates with only one positive case in 2007, 
the HIV status had not inﬂ uenced rapid test performance. 
In this case, the test has showed to be simple, accurate and 
feasible, with adequate sensibility and specifi city. Based on 
this data, the immuno-chromatographic test for anti-HCV 
showed to be appropriated for population-based studies, in 
settings with limited facilities or when rapid results are re-
quired.
In conclusion, our data show high prevalence of anti-
HCV positivity associated with familial history of hepatitis 
in a small town of south Brazil. The immuno-chromato-
graphic rapid test has shown to be effi cient in population 
based surveys.
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